Article Details

Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion

Retrieved on: 2025-01-15 20:08:43

Tags for this article:

Click the tags to see associated articles and topics

Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion. View article details on hiswai:

Excerpt

... Polaris Partners, boosting its efforts to develop intranasal antibody therapies targeting respiratory viruses, including influenza … more ...

Article found on: european-biotechnology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo